logo

For the Inventor, By the Inventor

Skokie, IL, United States of America

Praveen Thumbikat

This inventor holds 8 USPTO granted patents and 5 published patent applications. Top assignee: Northwestern University. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Praveen Thumbikat. Retrieved from https://idiyas.com/inventor/praveen-thumbikat

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 87.5

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 27(Granted Patents)


Location History:

  • Skokie, IL (US) (2013 - 2015)
  • Morton Grove, IL (US) (2013 - 2015)
  • Chicago, IL (US) (2020 - 2024)

Company Filing History:

goldMedal7 out of 2,217 
 
Northwestern University
 patents
where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...
8 patents (USPTO):Explore Patents
1. 12233080 - Lipotechoic acid for immune modulation (2025-02-25),
2. 11865144 - Immunostimulatory bacteria for the treatment of cancer (2024-01-09),
3. 11857531 - Combination mast cell inhibition for treatment of BPH/LUTS (2024-01-02),
4. 10799520 - Lipotechoic acid for immune modulation (2020-10-13),
5. 9181577 - Treatment of chronic pelvic pain syndrome (2015-11-10),
6. 8969340 - Methods for treating chronic pelvic pain syndrome (2015-03-03),
7. 8586044 - Treatment of chronic pelvic pain syndrome (2013-11-19),
8. 8481035 - Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A (2013-07-09),

Title: Praveen Thumbikat: Innovator in Immune Modulation and Cancer Treatment

Introduction

Praveen Thumbikat is a notable inventor based in Skokie, IL (US). He has made significant contributions to the fields of immune modulation and cancer treatment, holding a total of 8 patents. His innovative work focuses on utilizing unique compositions and methods to address critical health issues.

Latest Patents

Among his latest patents is a composition comprising lipotechoic acid (LTA) for immune modulation. This invention provides methods for treating autoimmune and inflammation-related conditions, such as chronic pelvic pain syndrome (CPPS) and arthritis. Another significant patent involves immunostimulatory bacteria for cancer treatment, specifically using uropathogenic bacteria to treat prostate cancer.

Career Highlights

Praveen Thumbikat is affiliated with Northwestern University, where he continues to advance his research and innovations. His work has garnered attention for its potential to improve treatment options for patients suffering from various diseases.

Collaborations

He has collaborated with esteemed colleagues, including Anthony J Schaeffer and David J Klumpp, to further enhance the impact of his research.

Conclusion

Praveen Thumbikat's contributions to immune modulation and cancer treatment exemplify the power of innovation in addressing complex health challenges. His ongoing research and patents continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…